Bifido Selected for 'Overseas Standard Certification Support Project'... Pursuing GRAS Certification for 'ND88' Strain

Bifido has received government support and plans to accelerate the GRAS certification of the ‘ND88’ strain.

Bifido, a microbiome specialist company based on Bifidobacterium (CEOs Shin Yong-cheol and Park Myung-soo), announced on the 16th that it has been selected for the ‘2024 Overseas Standard Certification Acquisition Support Project’ hosted by the Ministry of SMEs and Startups.

Through this support project, Bifido will receive assistance for the GRAS (Generally Recognized As Safe) certification process of its independently developed ‘ND88 (Lactiplantibacillus plantarum, hereafter ND88)’ strain. Upon completion of the certification, it is expected to accelerate entry into overseas markets and strengthen competitiveness in the global market.

The reason Bifido was selected for this support project lies in ▲the excellence of the ND88 strain ▲the importance of GRAS certification. The ND88 strain is a lactic acid bacterium independently developed by Bifido, with outstanding productivity and stability, holding great potential in the global market. GRAS certification is a recognition by the U.S. Food and Drug Administration (FDA) that a substance is safe for use in food, and obtaining this certification can provide a crucial foothold for entering the U.S. market. Additionally, through this Overseas Standard Certification Acquisition Support Project selection, Bifido received benefits such as partial support for certification fees, testing fees, and consultation (consulting) fees required to obtain GRAS certification.

A Bifido representative stated, “We are very pleased to start the GRAS certification process for the ND88 strain through this government support,” and added, “We expect this to further strengthen Bifido’s product competitiveness in the global market, including the United States.” They also mentioned, “We plan to acquire various additional overseas standard certifications in the future to expand our presence in the global market.”

Meanwhile, Bifido has already successfully obtained GRAS certification for three strains. Bifido’s representative strains ‘BNG4’, ‘BORI’, and ‘AD011’ have gained high credibility in the global market through GRAS certification and successfully entered overseas markets. Based on these successful cases, the ND88 strain is also expected to grow into an internationally recognized product through GRAS certification.

This content was produced with the assistance of AI translation services.